Genus (LON:GNS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Berenberg Bank in a report issued on Thursday, Digital Look reports. They currently have a GBX 3,350 price target on the stock. Berenberg Bank’s target price indicates a potential upside of 62.95% from the company’s current price.
Genus Price Performance
Genus stock opened at GBX 2,055.83 on Thursday. The stock has a market cap of £1.37 billion, a price-to-earnings ratio of 28.96, a price-to-earnings-growth ratio of 2.87 and a beta of 0.90. The company has a debt-to-equity ratio of 51.73, a current ratio of 2.25 and a quick ratio of 1.08. Genus has a 1 year low of GBX 1,943 and a 1 year high of GBX 3,220. The firm has a 50-day moving average of GBX 2,223.11 and a two-hundred day moving average of GBX 2,382.24.
Genus (LON:GNS – Get Free Report) last issued its earnings results on Thursday, September 10th. The company reported GBX 110.30 EPS for the quarter. Genus had a net margin of 7.07% and a return on equity of 9.70%. On average, research analysts forecast that Genus will post 70.9644323 earnings per share for the current year.
Insiders Place Their Bets
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
- Five stocks we like better than Genus
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
